These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7249258)

  • 1. Are all stage III cancers of the ovary really cancers of the ovary?
    Omura GA
    Cancer Clin Trials; 1981; 4(2):219-20. PubMed ID: 7249258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.
    Soliman PT; Slomovitz BM; Broaddus RR; Sun CC; Oh JC; Eifel PJ; Gershenson DM; Lu KH
    Gynecol Oncol; 2004 Aug; 94(2):456-62. PubMed ID: 15297188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH
    Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E; Deavers MT; Silva EG; Malpica A
    Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary appendiceal malignancy mimicking advanced stage ovarian carcinoma: a case series.
    McBroom JW; Parker MF; Krivak TC; Rose GS; Crothers B
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):388-90. PubMed ID: 10985900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult bilateral involvement in stage I epithelial ovarian cancer.
    Benjamin I; Morgan MA; Rubin SC
    Gynecol Oncol; 1999 Mar; 72(3):288-91. PubMed ID: 10053097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy.
    Sugiyama T; Kamura T; Kigawa J; Terakawa N; Kikuchi Y; Kita T; Suzuki M; Sato I; Taguchi K
    Cancer; 2000 Jun; 88(11):2584-9. PubMed ID: 10861437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mistaken diagnosis of carcinoma of the ovary.
    McGowan L; Norris HJ
    Surg Gynecol Obstet; 1991 Sep; 173(3):211-5. PubMed ID: 1925882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaplastic carcinoma in mucinous ovarian tumors: a clinicopathologic study of 34 cases emphasizing the crucial impact of stage on prognosis, their histologic spectrum, and overlap with sarcomalike mural nodules.
    Provenza C; Young RH; Prat J
    Am J Surg Pathol; 2008 Mar; 32(3):383-9. PubMed ID: 18300813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of postoperative follow-up and surgical treatment for Krukenberg tumor from colorectal cancers.
    Sakakura C; Hagiwara A; Yamazaki J; Takagi T; Hosokawa K; Shimomura K; Kin S; Nakase Y; Fukuda K; Yamagishi H
    Hepatogastroenterology; 2004; 51(59):1350-3. PubMed ID: 15362750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical presentation of microscopically advanced ovarian carcinoma.
    Mendez LE; Majmudar B; Horowitz IR
    South Med J; 2000 Mar; 93(3):321-2. PubMed ID: 10728524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of prognostic factors in common ovarian tumors of varying malignancy].
    Demeter A; Várkonyi T; Csapó Z; Szánthó A; Oláh J; Papp Z
    Magy Onkol; 2004; 48(3):259-65. PubMed ID: 15520877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases.
    Low JJ; Perrin LC; Crandon AJ; Hacker NF
    Cancer; 2000 Jul; 89(2):391-8. PubMed ID: 10918171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary peritoneal carcinoma presenting on routine papanicolaou smear.
    Olsen TG; Nycum LR; Graham RL; Alagoz T
    Gynecol Oncol; 2000 Jul; 78(1):71-3. PubMed ID: 10873414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual presentation of cervical cancer as advanced ovarian cancer.
    Abdulhathi MB; Al-Salam S; Kassis A; Ghazal-Aswad S
    Arch Gynecol Obstet; 2007 Oct; 276(4):387-90. PubMed ID: 17440746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.